PURPOSE: To determine the effects of magnesium (Mg2+) supplementation on performance and recovery in physically active women using the sensitive and recently advanced measure of ionic Mg2+ (iMg). METHODS:Participants (N = 121) were screened for [iMg] in plasma, with 44 (36.4%) exhibiting [iMg] below the normal range of 0.53-0.67 mmol.L-1 (4). Thirty-two subjects (21 +/- 3 yr) representing a broad range of [iMg] (0.54 +/- 0.04 mmol.L-1) completed the main 14-wk study. At baseline, participants submitted to a resting blood pressure measurement, and they completed both an anaerobic treadmill test and an incremental (aerobic) treadmill test. For the latter, values for workload, oxygen uptake, and heart rate were obtained at both anaerobic threshold and maximal effort. Blood samples for iMg, total serum Mg2+ (TMg), erythrocyte Mg2+ (EMg), Ca2+, K+, Na+, hemoglobin, hematocrit, lactate, and glucose were also collected pretest, and 4, 10, 30 min, and 24 h posttest. Subjects received 212 mg.d-1 Mg oxide or placebo in a double-blind fashion and were retested after 4 wk. After a 6-wk washout period, the testing was repeated with a treatment crossover. RESULTS:Ionic Mg2+ increased with Mg2+ treatment versus placebo (P < 0.05); however, performance and recovery indices were not significantly affected. CONCLUSION: Four weeks of 212 mg.d-1 Mg oxide supplementation improves resting [iMg] levels but not performance or recovery in physically active women.
RCT Entities:
PURPOSE: To determine the effects of magnesium (Mg2+) supplementation on performance and recovery in physically active women using the sensitive and recently advanced measure of ionic Mg2+ (iMg). METHODS:Participants (N = 121) were screened for [iMg] in plasma, with 44 (36.4%) exhibiting [iMg] below the normal range of 0.53-0.67 mmol.L-1 (4). Thirty-two subjects (21 +/- 3 yr) representing a broad range of [iMg] (0.54 +/- 0.04 mmol.L-1) completed the main 14-wk study. At baseline, participants submitted to a resting blood pressure measurement, and they completed both an anaerobic treadmill test and an incremental (aerobic) treadmill test. For the latter, values for workload, oxygen uptake, and heart rate were obtained at both anaerobic threshold and maximal effort. Blood samples for iMg, total serum Mg2+ (TMg), erythrocyte Mg2+ (EMg), Ca2+, K+, Na+, hemoglobin, hematocrit, lactate, and glucose were also collected pretest, and 4, 10, 30 min, and 24 h posttest. Subjects received 212 mg.d-1 Mg oxide or placebo in a double-blind fashion and were retested after 4 wk. After a 6-wk washout period, the testing was repeated with a treatment crossover. RESULTS: Ionic Mg2+ increased with Mg2+ treatment versus placebo (P < 0.05); however, performance and recovery indices were not significantly affected. CONCLUSION: Four weeks of 212 mg.d-1 Mg oxide supplementation improves resting [iMg] levels but not performance or recovery in physically active women.
Authors: R Terink; M G Balvers; C C W G Bongers; T M H Eijsvogels; R F Witkamp; M Mensink; M T Hopman; J M T Klein Gunnewiek Journal: J Nutr Health Aging Date: 2019 Impact factor: 4.075
Authors: Charles James Steward; Yue Zhou; Gary Keane; Matthew David Cook; Yunyi Liu; Tom Cullen Journal: Eur J Appl Physiol Date: 2019-10-17 Impact factor: 3.078